Early intervention for mild or borderline pulmonary arterial hypertension (PAH) associated with connective tissue diseases
Not Applicable
- Conditions
- Pulmonary arterial hypertension (PAH) associated with connective tissue disease
- Registration Number
- JPRN-UMIN000001350
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1) Hypersensitivity to Sildenafil or Beraprost. 2) Patients with chronic pulmonary thromboembolism. 3) Patients who will be on home oxygen therapy 4) Patients who will be classified as WHO class III or IV 5) Patients with severe ischemic heart diseases or cardiomyopathy 6) Patients with malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to clinical worsening
- Secondary Outcome Measures
Name Time Method